Antimicrobial stewardship programs: A review for the formulary decision-maker

Formulary

Volumn 48, Issue 1, 2013, Pages 7-18

  Gauthier, Timothy P ^a   Unger, Nathan R ^a  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DAPTOMYCIN; LINEZOLID; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ANTIMICROBIAL STEWARDSHIP PROGRAM; AWARENESS; CLINICAL PRACTICE; CLINICAL PROTOCOL; COST CONTROL; DECISION MAKING; DRUG COST; DRUG FORMULATION; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HUMAN; INFORMATION TECHNOLOGY; MEDICAL EDUCATION; MOTIVATION; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT SAFETY; PERSONNEL; POLITICS; PUBLICATION; REVIEW;

EID: 84874220201     PISSN: 1082801X     EISSN: 19381166     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Appelbaum P. 2012 and beyond: potential for the start of a second pre-antibiotic era? J Antimicrob Chemother. 2012;67:2062-2068.
2. Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: no ESKAPE! an update from the infectious diseases society of America. Clin Infect Dis. 2009;48:1-12.
3. Peterson LR. Bad bugs, no drugs: no ESCAPE revisited. Clin Infect Dis. 2009;49:992.
4. Wise R. The urgent need for new antibacterial agents. J Antimicrob Chemother. 2011;66:1939-1940.
5. Piddock LJ. The crisis of no new antibioticswhat is the way forward? Lancet Infect Dis. 2012;12:249-253.
6. White AR. Effective antibacterials: at what cost? the economics of antibacterial resistance and its control. J Antimicrob Chemother. 2011;66:1948-1953.
7. Spellberg B, Brass EP, Bradley JS, et al. White paper: recommendations on the conduct of superiority and organism-specifc clinical trials of antibacterial agents for the treatment of infections caused by drug-resistant bacterial pathogens. Clin Infect Dis. 2012;55(8):1031-1046.
8. Alanis AJ. Resistance to antibiotics: are we in the post-antibiotic era? Arch Med Res. 2005;36:697-705.
9. Bush K, Courvalin P, Dantas G, et al. Tackling antibiotic resistance. Nat Rev Microbiol. 2011;9:894-896.
10. Bartlett JG. A call to arms: the imperative for antimicrobial stewardship. Clin Infect Dis. 2011;53(S1):S4-S7.
11. Spelberg B, Guidos R, Bradley J, et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the infectious diseases society of America. Clin Infect Dis. 2008;46:155-164.
12. Savard P, Perl TM. A call for action: managing the emergence of multidrug-resistant Enterobacteriaceae in the acute care setting. Curr Opin Infect Dis. 2012;25:371-377.
13. Dellit TH, Owens RC, McGowan JE, et al. Infectious diseases society of America and the society for healthcare epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159-177.
14. Louie T. Antimicrobial stewardship: a review. Infect Dis Clin Pract. 2011;19(6):382-387.
15. Doron S, Davidson L. Antimicrobial stewardship. Mayo Clin Proc. 2011;86(11):1113-1123.
16. Ohl CA, Luther VP. Antimicrobial stewardship for inpatient facilities. J Hosp Med. 2011;6(S1):S4-S15.
17. Lesprit P, Brun-Buisson C. Hospital antibiotic stewardship. Curr Opin Infect Dis. 2008;21:344-349.
18. Drew RH, White R, MacDougall C, Hermsen ED, Owens RC. Insights from the society of infectious diseases pharmacists on antimicrobial stewardship guidelines from the infectious diseases society of America and the society for healthcare epidemiology of America. Pharmacother. 2009;29(5):593-607.
19. Drew RH. Antimicrobial stewardship programs: how to start and steer a successful program. J Manag Care Pharm. 2009;15(S2):S18-S23.
20. Patel D, MacDougall C. How to make antimicrobial stewardship work: practical considerations for hospitals of all sizes. Hosp Pharm. 2010;45(S1):S10-18.
21. Goff DA, Bauer KA, Reed EE, Stevenson KB, Taylor JJ, West JE. Is the "low-hanging fruit" worth picking for antimicrobial stewardship programs? Clin Infect Dis. 2012;55(4):587-592.
22. Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing-2010. Am J Health-Syst Pharm. 2011;68:669-688.
23. Daneman N, Gruneir A, Newman A, et al. Antibiotic use in long-term care facilities. J Antimicrob Chemother. 2011;66:2856-2863.
24. Pate PG, Storey DF, Baum DL. Implementation of an antimicrobial stewardship program at a 60-bed long-term acute care hospital. Infect Control Hosp Epidemiol. 2012;33(44):405-408.
25. Van Schooneveld T, Miller H, Sayles H, Watkins K, Smith PW. Survey of antimicrobial stewardship practices in Nebraska long-term care facilities. Infect Control Hosp Epidemiol. 2011;32(7):732-734.
26. Smith PW, Bennett G, Bradley S, et al. SHEA/APIC guideline: infection prevention and control in the long-term care facility. Am J Infect Control. 2008;36:504-535.
27. Owens RC, Shorr AF, Deschambeault AL. Antimicrobial stewardship: shepherding precious resources. Am J Health-Syst Pharm. 2009;66(S4):S15-S22.
28. American Hospital Association website. Available from http://www.aha.org/research/rc/stat-studies/fast-facts.shtml. Updated January 3, 2012. Accessed November 19, 2012.
29. Ohl CA, Dodds Ashley ES. Antimicrobial stewardship programs in community hospitals: the evidence base and case studies. Clin Infect Dis. 2011;53(S1):S23-S28.
30. Bird ML, Dunn RL, Hagemann TM, Burton M, Britton ML, St. Cyr MB. Collaboration between a college of pharmacy and a for-proft health system at an academic medical center. Am J Health-Syst Pharm. 2012;69:1150-1156.
31. Palmer HR, Weston J, Gentry L, et al. Improving patient care through implementation of an antimicrobial stewardship program. Am J Health-Syst Pharm. 2011;68:2170-2174.
32. Camins BC, King MD, Wells JB, et al. Impact of an antimicrobial utilization program on antimicrobial use at a large teaching hospital: a randomized control trial. Infect Control Hosp Epidemiol. 2009;30:931-938.
33. Michaels K, Mahdavi M, Krug A, Kuper K, et al. Implementation of an antimicrobial stewardship program in a community hospital: results of a three-year analysis. Hosp Pharm. 2012;47(8):608-616.
34. Nowak MA, Nelson RE, Breidenbach JL, Thompson PA, Carson PJ. Clinical and economic outcomes of a prospective antimicrobial stewardship program. Am J Health-Syst Pharm. 2012;69:1500-1508.
35. MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev. 2005;18(4):638-656.
36. Johannsson B, Beekmann SE, Srinivasan A, Hersh AL, Laxminarayan R, Polgreen PM. Improving antimicrobial stewardship: the evolution of programmatic strategies and barriers. Infect Control Hosp Epidemiol. 2011;32(4):367-374.
37. Hoffman JM, Li E, Doloresco F, et al. Projecting future drug expenditures-2012. Am J Health-Syst Pharm. 2012;69:e5-e21.
38. Doloresco F, Fominaya C, Schumock GT, et al. Projecting future drug expenditures-2011. Am J Health-Syst Pharm. 2011;68:e1-e12.
39. Hoffman JM, Doloresco F, Vermeulen LC, et al. Projecting future drug expenditures-2010. Am J Health-Syst Pharm. 2010;67:919-928.
40. Hoffman JM, Shah ND, Vermeulen LC, et al. Projecting future drug expenditures-2009. Am J Health-Syst Pharm. 2009;66:237-257.
41. Hoffman JM, Shah ND, Vermeulen LC, et al. Projecting future drug expenditures-2008. Am J Health-Syst Pharm. 2008;65:234-253.
42. Eisenstein BI, Oleson FB, Baltz RH. Daptomycin: from the mountain to the clinic, with essential help from Francis Tally, MD. Clin Infect Dis. 2010;50(S1):S10-S15.
43. Po JL, Nguyen BQ, Carling PC. The impact of an infectious diseases specialist-directed computerized physician order entry antimicrobial stewardship program targeting linezolid use. Infect Control Hosp Epidemiol. 2012;33:434-435.
44. Beardsley JR, Williamson JC, Johnson JW, Luther VP, Wrenn RH, Ohl CC. Show me the money: long-term fnancial impact of an antimicrobial stewardship program. Infect Control Hosp Epidemiol. 2012;33(4):398-400.
45. Toth NR, Chambers RM, Davis SL. Implementation of a care bundle for antimicrobial stewardship. Am J Health-Syst Pharm. 2010;67:746-749.
46. LaRosa LA, Fishman NO, Lautenbach E, Koppel R, Morales KH, Linkin DR. Evaluation of antimicrobial therapy orders circumventing an antimicrobial stewardship program: investigating the strategy of "stealth dosing". Infect Control Hosp Epidemiol. 2007;28:551-556.
47. Peterson LR. Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance. Clin Microbiol Infect. 2005;11(S5):S4-S16.
48. Rahal JJ, Urban C, Horn D, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA. 1998;280:1233-1237.
49. Wong-Beringer A, Nguyen K, Razeghi J. Implementing a program for switching from i.v. to oral antimicrobial therapy. Am J Health-Syst Pharm. 2001;58:1146-1149.
50. Jones M, Huttner B, Madaras-Kelly K, et al. Parenteral to oral conversion of fuoroquinolones: low-hanging fruit for antimicrobial stewardship programs? Infect Control Hosp Epidemiol. 2012;33(4):362-367.
51. Kaufman SE, Donnell RW, Hickey SW. Rationale and evidence for extended infusion of piperacillin-tazobactam. Am J Health-Syst Pharm. 2011;68:1521-1526.
52. Yost RJ, Cappalletty DM, et al. The retrospective cohort of extended-infusion piperacillin-tazobactam (RECIEPT) study: a multicenter study. Pharmacother. 2011;31(8):767-775.
53. Xamplas RC, Itokazu GS, Glowacki RC, Grasso AE, Caquelin C, Schwartz DN. Implementation of an extended-infusion piperacillin-tazobactam program at an urban teaching hospital. Am J Health-Syst Pharm. 2010;67:622-628.
54. Heinrich LS, Tokumaru S, Clark NM, Garofalo J, Paek JL, Grim SA. Development and implementation of a piperacillin-tazobactam extended infusion guideline. J Pharm Pract. 2011;24:571-576.
55. Lodise TP, Lomaestro B, Drusano GL. Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy. Clin Infect Dis. 2007;44:357-363.
56. McGowan JE. Antimicrobial stewardshipthe state of the art in 2011: focus on outcome and methods. Infect Control Hosp Epidemiol. 2012;33(4):331-337.
57. Dryden M, Saeed K, Townsend R, et al. Antibiotic stewardship and early discharge from hospital: impact of a structured approach to antimicrobial management. J Antimicrob Chemo. 2012;67:2289-2296.
58. Neidell MJ, Cohen B, Furuya Y, et al. Costs of health-care and community-associated infections with antimicrobial resistant versus antimicrobial-susceptible organisms. Clin Infect Dis. 2012;55(6):807-815.
59. Lim LM, Ly B, Anderson D, et al. Resurgence of colistin use: a review of resistance, toxicity, pharmacodynamics, and dosing. Pharmacother. 2010;30(12):1279-1291.
60. Paterson DL. "Collateral damage" from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis. 2004;38(S4):S341-S345.
61. Debast SB, Vassen N, Choudry A, Wiegers-Ligvoet EAJ, Van Den Berg RJ, Kuijper EJ. Successful combat of an outbreak due to Clostridium diffcile PCR ribotype 027 and recognition of specifc risk factors. Clin Microbiol Infect. 2009;15:427-434.
62. Aldeyab MA, Kearney MP, Scott MG, et al. An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium diffcile infection in the hospital setting. J Antimicrob Chemother. 2012 Aug 16:[Epub ahead of print].
63. Dubberke E. Clostridium diffcile infection: the scope of the problem. J Hosp Med. 2012;7(S3):S1-S4.
64. Lexi-Comp, Inc. (Lexi-DrugsTM). Hudson, OH: Lexi-Comp, Inc.; v1.10.0(159), October 12, 2012.
65. Tran TT, Palmer HR, Weston J, et al. Evaluation of a daptomycin dose-optimization protocol. Am J Health-Syst Pharm. 2012;69:979-984.
66. Pagani L, Gyssens IC, Huttner B, Nathwani D, Harbarth S. Navigating the web in search of resources on antimicrobial stewardship in health care institutions. Clin Infect Dis. 2009;48:626-632.
67. Goff DA. iPhones, iPads, and medical applications for antimicrobial stewardship. Pharmacother. 2012;32(7):657-661.
68. American College of Clinical Pharmacy Website. Available from http://www.accp.com/docs/careers/BPS_news_release_06012012.pdf. Accessed November 19, 2012.
69. Healthcare. gov website. Available from www.healthcare.gov/law/index.html. Accessed November 19, 2012.